The FDA’s anti-smoking campaign warning teens about “The Real Cost” of cigarettes was successful at preventing smoking initiation, according to the results of a nationwide survey. However, another study found that levels of e-cigarette use have increased among adolescents unlikely to start smoking cigarettes.
The FDA’s anti-smoking campaign warning teens about “The Real Cost” of cigarettes was successful at preventing smoking initiation, according to the results of a nationwide survey. However, another study found that levels of e-cigarette use have increased among adolescents unlikely to start smoking cigarettes.
The “Real Cost” campaign, which was the first federally funded tobacco education campaign when it began in 2014, aimed to prevent youth from trying cigarettes by reinforcing the central theme “Every cigarette costs you something.” The messages, which appeared on television, online, and in magazines, illustrated the loss of control due to nicotine addiction, the detrimental effects of smoking on one’s appearance, and the harmful mix of toxic chemicals present in cigarette smoke.
According to the results of a cohort study of US teenagers, the campaign achieved significant success in preventing smoking initiation. Of the 5185 respondents aged 11 to 16 who had never smoked at the beginning of the surveys, high exposure to the campaign was associated with a 30% decrease in the risk of starting to smoke. Additional analysis determined that an estimated 348,498 adolescents were potentially prevented from initiating smoking during the 2-year campaign period.
The study authors attributed the campaign’s success to the evidence-based development of its messaging and the high saturation across multiple channels of media aimed at this age group.
“These results demonstrate the effectiveness of a national campaign that focused on the harmful effects of smoking and delivered salient messages that resonated with youths,” they wrote. “Sustained tobacco education campaigns such as ‘The Real Cost’ can encourage US youths to abstain from tobacco use and accelerate progress toward future tobacco-free generations.”
However, not all recent research on teen nicotine use has been so encouraging. A new study published in Pediatrics indicated that e-cigarette use is not responsible for the decline in smoking rates among adolescents, as had been previously suggested. In fact, the researchers found that e-cigarettes are attracting young people who were at low risk of beginning to smoke traditional cigarettes.
The study analyzed several psychosocial characteristics common among smokers, like living with a smoker or wearing clothing with tobacco company logos. The cigarette smokers among the 140,000 middle and high school students surveyed between 2004 and 2014 generally displayed these characteristics, but those who just used e-cigarettes were less likely to report these qualities. A predictive model using these characteristics identified less than 25% of the e-cigarette users as likely to be current smokers.
“The introduction of e-cigarettes was not associated with a change in the linear decline in cigarette smoking among youth,” the authors concluded. “E-cigarette—only users would be unlikely to have initiated tobacco product use with cigarettes.”
In May 2016, the FDA expanded its authority to cover all tobacco products, allowing it to ban the sale of e-cigarettes to anyone younger than 18 and require manufacturers to include a nicotine warning on the packaging. However, concerns persisted about the prevalence of e-cigarette advertising that targeted teenagers.
A report on youth e-cigarette use issued by the Surgeon General in December 2016 accused e-cigarette marketing of “promoting flavors and using a wide variety of media channels and approaches” similar to those that had previously been used to attract young people to conventional cigarettes. It suggested steps like “regulation of e-cigarette marketing likely to attract youth, and educational initiatives targeting youth and young adults.”
In the report’s preface, CDC Director Thomas R. Frieden, MD, MPH, cited the FDA’s “Real Cost” campaign as an example of a “hard-hitting media campaign” that could be adapted to prevent young people from trying e-cigarettes or moving from experimentation to regular use.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More